Results 141 to 150 of about 575,334 (316)
This study aims to elucidate prognostic outcomes of hepatectomy versus RFA for primary 2–3 cm HCC. Hepatectomy may offer superior prognostic benefits, especially in those with elevated AFP levels. The local recurrence rate in hepatectomy is significantly lower than RFA.
Yuki Kitano +8 more
wiley +1 more source
Chronic hepatitis B: Is it time for expanded antiviral treatment? [PDF]
Manrai M, Jha AA, Pachisia AV, Dawra S.
europepmc +1 more source
Hepatitis B antigen-associated deoxyribonucleic acid polymerase activity and e antigen/anti-e system
Masayuki Imai +4 more
openalex +1 more source
Hepatitis B antigen in saliva, urine, and stool [PDF]
Gilbert R. Irwin +7 more
openalex +1 more source
This study investigated the impacts of distance to transplant center on posttransplant survival following LDLT. Patients living further away from the transplant center had worse graft and patient survival rates than those of patients living closer, probably due to less frequency of follow‐up visits, and living > 40 miles from our treatment center was ...
Hajime Matsushima +9 more
wiley +1 more source
Antibody To Hepatitis B Core Antigen In Patients With Hepatocellular Carcinoma
Yasuhiko Kubo +8 more
openalex +1 more source
Sequential hepatic vein embolization (HVE) following portal vein embolization (PVE) significantly improves both the volume and function of the future remnant liver (FRL) compared to PVE alone. In this study, the FRL regeneration rates for volume and function were markedly higher and faster in the PVE–HVE group, with no differences in surgical outcomes ...
Thanh Tung Lai +9 more
wiley +1 more source
Opportunities and challenges for hepatitis B cure in people living with HIV and hepatitis B virus. [PDF]
Singh KP, Audsley J, Zhao W, Lewin SR.
europepmc +1 more source
Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection. [PDF]
Mukunda B. Ray +5 more
openalex +1 more source
This multicenter study suggests that adjuvant chemotherapy may improve survival in stage IV intrahepatic cholangiocarcinoma after resection, with S‐1 showing a potential survival advantage. ABSTRACT Background The survival benefit of adjuvant chemotherapy (AC) in intrahepatic cholangiocarcinoma (ICC) remains uncertain, particularly in advanced‐stage ...
Hisashi Kosaka +9 more
wiley +1 more source

